Serum levels of sFas and sFasL during chemotherapy of lung cancer
The aim of this study was to assess the clinical usefulness of determination of soluble Fas (sFas) and soluble Fas Ligand (sFasL) during chemotherapy of lung cancer. Methods: The study included 80 patients (69 males; 11 females; mean age 64 years; 48 with non-small cell lung cancer-NSCLC, 32 with sm...
Saved in:
| Date: | 2007 |
|---|---|
| Main Authors: | , , , |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2007
|
| Series: | Experimental Oncology |
| Subjects: | |
| Online Access: | http://dspace.nbuv.gov.ua/handle/123456789/138576 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Serum levels of sFas and sFasL during chemotherapy of lung cancer / W. Naumnik, T. Iżycki, M. Ossolińska, E. Chyczewska // Experimental Oncology. — 2007. — Т. 29, № 2. — С. 132–136. — Бібліогр.: 23 назв. — англ. |